3rd Quarter - Report

CROSSROADS STRATEGIES, LLC for GINKGO BIOWORKS, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Education and outreach on automated lab technology; FY2027 National Defense Authorization Act (H.R.8800/S.4784).

Contacted: Executive Office of the President (EOP); SENATE; Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Energy, Dept of

Bills named: S. 4784 (119th), H.R. 8800 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.